Torrent Pharma Q3 Net zooms 3-fold to Rs 483 crore
New Delhi: Drug firm Torrent Pharma reported around three-fold jump in consolidated net profit at Rs 483 crore for the December quarter.The company had posted a net profit of Rs 167 crore in the same quarter of the previous fiscal, Torrent Pharmaceuticals said in a BSE filing.Company's consolidated total income rose to Rs 1,539 crore during the quarter under review as against Rs 116.8 crore...
Login or Register to read the full article
New Delhi: Drug firm Torrent Pharma reported around three-fold jump in consolidated net profit at Rs 483 crore for the December quarter.
The company had posted a net profit of Rs 167 crore in the same quarter of the previous fiscal, Torrent Pharmaceuticals said in a BSE filing.
Company's consolidated total income rose to Rs 1,539 crore during the quarter under review as against Rs 116.8 crore in the year-ago period, it said.
In a separate filing, the firm said its board has approved an interim dividend of Rs 20 per equity share of Rs 5.
The dividend is expected to be paid/dispatched on February 19, 2016, it added.
The company had posted a net profit of Rs 167 crore in the same quarter of the previous fiscal, Torrent Pharmaceuticals said in a BSE filing.
Company's consolidated total income rose to Rs 1,539 crore during the quarter under review as against Rs 116.8 crore in the year-ago period, it said.
In a separate filing, the firm said its board has approved an interim dividend of Rs 20 per equity share of Rs 5.
The dividend is expected to be paid/dispatched on February 19, 2016, it added.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd